• Publications
  • Influence
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
Background and aims Antimicrobial drug resistance is a major cause of the failure of Helicobacter pylori eradication and is largely responsible for the decline in eradication rate. Quadruple therapyExpand
  • 146
  • 7
Effects of long‐term PPI treatment on producing bowel symptoms and SIBO
Eur J Clin Invest 2011; 41 (4): 380–386
  • 87
  • 4
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery.
BACKGROUND/AIM Bariatric surgery has proven efficacy in the modulation of a number of gut peptides that can contribute to improvement of diabetes and its associated metabolic changes. In order toExpand
  • 43
  • 4
Reviewing the term uniformitarianism in modern Earth sciences
Abstract Uniformitarianism is a classical term of the geological sciences, coined in 1832 by Whewell to indicate a specific part of Lyell's hypothesis. However, over the years uniformitarianism hasExpand
  • 34
  • 4
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Regulatory T cells (Tregs) are important for the induction and maintenance of peripheral tolerance therefore, they are key in preventing excessive immune responses and autoimmunity. In the lastExpand
  • 105
  • 3
  • PDF
IL-21 Is Highly Produced in Helicobacter pylori-Infected Gastric Mucosa and Promotes Gelatinases Synthesis1
Helicobacter pylori (Hp) infection is associated with gastric inflammation and ulceration. The pathways of tissue damage in Hp-infected subjects are complex, but evidence indicates that TExpand
  • 90
  • 3
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.
BACKGROUND & AIMS Helicobacter pylori (Hp) infection causes a chronic gastric inflammation, which can lead to peptic ulceration and cancer. The inflammatory response is multifactorial and isExpand
  • 61
  • 3
Eradication of Helicobacter pylori: a clinical update.
Helicobacter pylori is a ubiquitous gram-negative bacterium infecting half the world's population[1,2] and causing chronic active gastritis in virtually all infected individuals.[3] The majority ofExpand
  • 40
  • 3
Free-soluble and outer membrane vesicle-associated VacA from Helicobacter pylori: Two forms of release, a different activity.
Helicobacter pylori releases VacA both as free-soluble and as outer membrane vesicle (OMV)-associated toxin. In this study, we investigated the amount of VacA released in each of the two forms andExpand
  • 40
  • 3
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Knowledge on the role of Helicobacter pylori (HP) infection is continually evolving, and treatment is becoming more challenging due to increasing bacterial resistance. Since the management of HPExpand
  • 92
  • 2
  • PDF